DJ Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ advanced 1.01% to $54.98 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.24% to 6,144.15 and the Dow Jones Industrial Average rising 0.16% to 44,627.59.
This was the stock's second consecutive day of gains.
Bristol Myers Squibb Co. closed 10.02% below its 52-week high of $61.10, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.87% to $157.89, Pfizer Inc. $(PFE)$ rose 1.29% to $25.89, and Abbott Laboratories $(ABT)$ rose 1.50% to $132.13.
Trading volume (10.6 M) remained 540,416 below its 50-day average volume of 11.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 19, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 19, 2025 16:39 ET (21:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.